{"nct_id":"NCT02377921","title":"Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Sialic Acid in Patients With Glucosamine (UDP-N-acetyl)-2-epimerase Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)","status":"COMPLETED","status_verified_date":"2019-06","start_date":"2015-05-20","start_date_type":"ACTUAL","primary_completion_date":"2017-06-09","primary_completion_date_type":"ACTUAL","completion_date":"2017-06-09","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["RARE"]}